Mismatch negativity is a breakthrough biomarker for understanding and treating psychotic disorders.
作者信息
Light Gregory A, Näätänen Risto
机构信息
Mental Illness, Research, Education and Clinical Center, Veteran's Affairs San Diego Healthcare System.
出版信息
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15175-6. doi: 10.1073/pnas.1313287110. Epub 2013 Aug 30.
Abstract
摘要
相似文献
1
Mismatch negativity is a breakthrough biomarker for understanding and treating psychotic disorders.失配负波是理解和治疗精神障碍的一项突破性生物标志物。
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15175-6. doi: 10.1073/pnas.1313287110. Epub 2013 Aug 30.
2
Nonhuman primate model of schizophrenia using a noninvasive EEG method.使用非侵入性 EEG 方法的精神分裂症非人灵长类动物模型。
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15425-30. doi: 10.1073/pnas.1312264110. Epub 2013 Aug 19.
3
Cognitive event-related potentials in human and non-human primates: implications for the PCP/NMDA model of schizophrenia.人类和非人灵长类动物的认知事件相关电位：对精神分裂症的苯环己哌啶/ N-甲基-D-天冬氨酸模型的启示
Electroencephalogr Clin Neurophysiol Suppl. 1995;44:161-75.
4
Mice with subtle reduction of NMDA NR1 receptor subunit expression have a selective decrease in mismatch negativity: Implications for schizophrenia prodromal population.N-甲基-D-天冬氨酸（NMDA）NR1受体亚基表达略有降低的小鼠，其失配负波选择性下降：对精神分裂症前驱人群的意义。
Neurobiol Dis. 2015 Jan;73:289-95. doi: 10.1016/j.nbd.2014.10.010. Epub 2014 Oct 22.
5
Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.皮质 N-甲基-D-天冬氨酸受体在听觉感觉记忆及失配负波产生中的作用：对精神分裂症的启示
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11962-7. doi: 10.1073/pnas.93.21.11962.
6
Mismatch negativity: A simple and useful biomarker of N-methyl-d-aspartate receptor (NMDAR)-type glutamate dysfunction in schizophrenia.失配负波：精神分裂症中N-甲基-D-天冬氨酸受体（NMDAR）型谷氨酸功能障碍的一种简单且有用的生物标志物。
Schizophr Res. 2018 Jan;191:1-4. doi: 10.1016/j.schres.2017.11.006. Epub 2017 Nov 11.
7
A quantitative review of the postmortem evidence for decreased cortical N-methyl-D-aspartate receptor expression levels in schizophrenia: How can we link molecular abnormalities to mismatch negativity deficits?精神分裂症患者皮质N-甲基-D-天冬氨酸受体表达水平降低的死后证据的定量综述：我们如何将分子异常与失配负波缺陷联系起来？
Biol Psychol. 2016 Apr;116:57-67. doi: 10.1016/j.biopsycho.2015.10.013. Epub 2015 Nov 10.
8
Mismatch responses and deviance detection in N-methyl-D-aspartate (NMDA) receptor hypofunction and developmental models of schizophrenia.N-甲基-D-天冬氨酸（NMDA）受体功能减退与精神分裂症发育模型中的失配反应和偏差检测
Biol Psychol. 2016 Apr;116:75-81. doi: 10.1016/j.biopsycho.2015.06.015. Epub 2015 Jul 6.
9
Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.啮齿动物错配负波/θ神经振荡反应作为精神分裂症基于 N-甲基-D-天冬氨酸受体新型治疗开发的转化神经生理生物标志物。
Neuropsychopharmacology. 2018 Feb;43(3):571-582. doi: 10.1038/npp.2017.176. Epub 2017 Aug 17.
10
Plasma levels of dopamine metabolite correlate with mismatch negativity in patients with schizophrenia.精神分裂症患者血浆多巴胺代谢产物水平与失匹配负波相关。
Psychiatry Clin Neurosci. 2020 May;74(5):289-293. doi: 10.1111/pcn.12984. Epub 2020 Feb 15.
引用本文的文献
1
Features of mismatch negativity in an at-risk mental state with the traits associated with the autistic spectrum.具有与自闭症谱系相关特征的高危精神状态下失配负波的特点。
Front Psychiatry. 2025 Aug 14;16:1620954. doi: 10.3389/fpsyt.2025.1620954. eCollection 2025.
2
Moving toward precision and personalized treatment strategies in psychiatry.迈向精神医学的精准和个性化治疗策略。
Int J Neuropsychopharmacol. 2025 May 9;28(5). doi: 10.1093/ijnp/pyaf025.
3
Electroacupuncture stimulation of auricular concha region improves loss of control over stress induced depression-like behavior by modulating 5-hydroxytryptamine 1A receptor.电针刺激耳甲区通过调节5-羟色胺1A受体改善应激诱导的抑郁样行为失控。
J Tradit Chin Med. 2025 Apr;45(2):326-334. doi: 10.19852/j.cnki.jtcm.2025.02.014.
4
Altered theta band and theta/beta ratio in mismatch negativity associate with treatment effect in schizophrenia with auditory hallucinations.幻听型精神分裂症中，失配负波的θ频段及θ/β比值改变与治疗效果相关。
Schizophr Res Cogn. 2025 Jan 9;40:100344. doi: 10.1016/j.scog.2025.100344. eCollection 2025 Jun.
5
Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia.错配负波（MMN）作为精神分裂症 NMDA 受体和兴奋性/抑制性失衡靶向治疗的药效学/反应生物标志物。
Adv Neurobiol. 2024;40:411-451. doi: 10.1007/978-3-031-69491-2_15.
6
Interaction between BDNF Val66Met polymorphism and mismatch negativity for working memory capacity in schizophrenia.脑源性神经营养因子Val66Met多态性与精神分裂症工作记忆容量失配负波之间的相互作用
Schizophrenia (Heidelb). 2024 Aug 22;10(1):70. doi: 10.1038/s41537-024-00493-x.
7
Computational Synaptic Modeling of Pitch and Duration Mismatch Negativity in First-Episode Psychosis Reveals Selective Dysfunction of the N-Methyl-D-Aspartate Receptor.首发精神病中音调与时长失配负波的计算性突触模型揭示了N-甲基-D-天冬氨酸受体的选择性功能障碍。
Clin EEG Neurosci. 2025 Jan;56(1):22-34. doi: 10.1177/15500594241238294. Epub 2024 Mar 27.
8
Clarifying directional dependence among measures of early auditory processing and cognition in schizophrenia: leveraging Gaussian graphical models and Bayesian networks.厘清精神分裂症早期听觉处理和认知测量指标之间的方向依赖性：利用高斯图形模型和贝叶斯网络。
Psychol Med. 2024 Jul;54(9):1930-1939. doi: 10.1017/S0033291724000023. Epub 2024 Jan 30.
9
Top-down input modulates visual context processing through an interneuron-specific circuit.自上而下的输入通过特定于中间神经元的回路调节视觉上下文处理。
Cell Rep. 2023 Sep 26;42(9):113133. doi: 10.1016/j.celrep.2023.113133. Epub 2023 Sep 19.
10
Is source-resolved magnetoencephalographic mismatch negativity a viable biomarker for early psychosis?源分辨脑磁图失匹配负波能否成为早期精神病的可行生物标志物？
Eur J Neurosci. 2024 Apr;59(8):1889-1906. doi: 10.1111/ejn.16107. Epub 2023 Aug 3.
本文引用的文献
1
Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice.啮齿动物 5C-CPT 的反向翻译表明，精神分裂症患者的注意力受损与东莨菪碱诱导的小鼠缺陷相似。
Transl Psychiatry. 2013 Nov 12;3(11):e324. doi: 10.1038/tp.2013.82.
2
Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity.精神分裂症和临床高风险患者的自动听觉处理缺陷：用失匹配负波预测精神病风险。
Biol Psychiatry. 2014 Mar 15;75(6):459-69. doi: 10.1016/j.biopsych.2013.07.038. Epub 2013 Sep 16.
3
Nonhuman primate model of schizophrenia using a noninvasive EEG method.使用非侵入性 EEG 方法的精神分裂症非人灵长类动物模型。
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15425-30. doi: 10.1073/pnas.1312264110. Epub 2013 Aug 19.
4
Demand and modality of directed attention modulate "pre-attentive" sensory processes in schizophrenia patients and nonpsychiatric controls.需求和注意指向模式调节精神分裂症患者和非精神病对照者的“前注意”感觉过程。
Schizophr Res. 2013 May;146(1-3):326-35. doi: 10.1016/j.schres.2013.01.035. Epub 2013 Mar 11.
5
Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state.错配负波与认知表现对有高危精神状态的个体发生精神病的预测作用。
PLoS One. 2013;8(1):e54080. doi: 10.1371/journal.pone.0054080. Epub 2013 Jan 17.
6
Neural substrates of normal and impaired preattentive sensory discrimination in large cohorts of nonpsychiatric subjects and schizophrenia patients as indexed by MMN and P3a change detection responses.以失匹配负波（MMN）和P3a变化检测反应为指标，在大量非精神疾病受试者和精神分裂症患者队列中，正常和受损的前注意感觉辨别神经基质。
Neuroimage. 2013 Feb 1;66:594-603. doi: 10.1016/j.neuroimage.2012.09.074. Epub 2012 Oct 22.
7
Next-generation treatments for mental disorders.精神障碍的下一代治疗方法。
Sci Transl Med. 2012 Oct 10;4(155):155ps19. doi: 10.1126/scitranslmed.3004873.
8
Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia.天使指明了道路吗？精神分裂症 PCP/NMDA 模型的病因和治疗意义。
Schizophr Bull. 2012 Sep;38(5):958-66. doi: 10.1093/schbul/sbs069.
9
Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia.精神分裂症基因组和临床结局研究中神经生理和神经认知生物标志物的特征。
PLoS One. 2012;7(7):e39434. doi: 10.1371/journal.pone.0039434. Epub 2012 Jul 3.
10
Disentangling early sensory information processing deficits in schizophrenia.解析精神分裂症早期感觉信息处理缺陷。
Clin Neurophysiol. 2012 Oct;123(10):1942-9. doi: 10.1016/j.clinph.2012.02.079. Epub 2012 May 18.
Zotero 插件